Article Details
Retrieved on: 2024-02-05 05:08:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses biotechnology advances in using extracellular vesicles (EVs), such as exosomes and microvesicles, as therapeutic agents, exploring their potential for treating degenerative retinal diseases like macular degeneration and retinitis pigmentosa.
Article found on: europe.ophthalmologytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here